Changeflow GovPing Healthcare FDA Variance Amendment from J.M.W. Entertainmen...
Routine Notice Added Final

FDA Variance Amendment from J.M.W. Entertainment Group

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published March 16th, 2026
Detected March 17th, 2026
Email

Summary

The FDA has posted a variance amendment from J.M.W. Entertainment Group, LLC. The document was made available on March 16, 2026, via the Regs.gov portal. No further details on the amendment's content are provided.

View original document View source feed page

What changed

The FDA has made available a variance amendment submitted by J.M.W. Entertainment Group, LLC, as posted on March 16, 2026. The document is listed under FDA-2026-V-1434-0003 on the Regs.gov platform. The specific nature or content of this amendment is not detailed in the provided information, and the full document is not directly accessible.

Given the limited information, compliance officers should note the existence of this filing. Further investigation may be required if J.M.W. Entertainment Group, LLC is a relevant entity within the organization's supply chain or operational scope. No immediate actions or deadlines are indicated by this notice.

Source document (simplified)

Content

There are no documents available to view or download

Attachments 1

Variance Amendment from The J.M.W. Entertainment Group, LLC

More Information
- Author(s) CDRH
Download

Related changes

Favicon for www.regulations.gov FDA Document on Contraceptive Status Among Females 15-49
Routine Mar 17, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov Hormonal Contraceptive Eligibility for Women at High HIV Risk
Priority review Mar 17, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov FDA Progestins Classification and Pharmacology
Routine Mar 17, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.contractsfinder.service.gov.uk DfE Renewal and Retrofit Programme Early Engagement Notice
Routine Mar 17, 2026 • Contracts Finder - Open Opportunities • Trade & Sanctions
Favicon for news.va.gov VA Accelerates Federal EHR Deployment
Routine Mar 17, 2026 • VA News • Government & Legislation
Favicon for www.whitehouse.gov Executive Order Establishing Task Force to Eliminate Fraud in Federal Programs
Priority review Mar 17, 2026 • White House: Fact Sheets • Government & Legislation

Source

Favicon for www.regulations.gov
Regs.gov: Food and Drug Administration regulations.gov/search?agencyIds=FDA&sortBy=postedDate&sortDirection=desc
Healthcare
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Published
March 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers
Geographic scope
National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices

Browse Categories

Agriculture & Food Safety 61 Banking & Finance 163 Consumer Protection 29 Courts & Legal 206 Data Privacy & Cybersecurity 58 Defense & National Security 48 Education 20 Energy 94 Environment 81 Government & Legislation 240 Healthcare 104 Housing 15 Immigration 8 Insurance 16 Labor & Employment 104 Pharma & Drug Safety 68 Securities & Markets 69 Tax 48 Telecom & Technology 34 Trade & Sanctions 113 Transportation 53

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.